Literature DB >> 24211137

Crystal structures of Sirt3 complexes with 4'-bromo-resveratrol reveal binding sites and inhibition mechanism.

Giang Thi Tuyet Nguyen1, Melanie Gertz, Clemens Steegborn.   

Abstract

Sirtuins are protein deacetylases regulating aging processes and various physiological functions. Resveratrol, a polyphenol found in red wine, activates human Sirt1 and inhibits Sirt3, and it can mimic calorie restriction effects, such as lifespan extension in lower organisms. The mechanism of Sirtuin modulation by resveratrol is not well understood. We used 4'-bromo-resveratrol (5-(2-(4-hydroxyphenyl)vinyl)-1,3-benzenediol) to study Sirt1 and Sirt3 modulation. Despite its similarity to the Sirt1 activator resveratrol, the compound potently inhibited both, Sirt1 and Sirt3. Crystal structures of Sirt3 in complex with a fluorophore-labeled and with a native substrate peptide, respectively, in presence of 4'-bromo-resveratrol reveal two compound binding sites. Biochemical studies identify the internal site and substrate competition as the mechanism for inhibition, providing a drug target site, and homology modeling suggests that the second, allosteric site might indicate the site for Sirt1 activation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24211137     DOI: 10.1016/j.chembiol.2013.09.019

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  28 in total

1.  Halistanol sulfates I and J, new SIRT1-3 inhibitory steroid sulfates from a marine sponge of the genus Halichondria.

Authors:  Fumiaki Nakamura; Norio Kudo; Yuki Tomachi; Akiko Nakata; Misao Takemoto; Akihiro Ito; Hodaka Tabei; Daisuke Arai; Nicole de Voogd; Minoru Yoshida; Yoichi Nakao; Nobuhiro Fusetani
Journal:  J Antibiot (Tokyo)       Date:  2017-11-29       Impact factor: 2.649

2.  Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3.

Authors:  Sanghoon Kwon; Sunmi Seok; Peter Yau; Xiaoling Li; Byron Kemper; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

3.  4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.

Authors:  Jasmine George; Minakshi Nihal; Chandra K Singh; Nihal Ahmad
Journal:  Mol Carcinog       Date:  2019-07-10       Impact factor: 4.784

4.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Stephan A Eisler; Ugo Perricone; Giosuè Lo Bosco; Giampaolo Barone; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

Review 5.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

Review 6.  Sirtuin activators and inhibitors: Promises, achievements, and challenges.

Authors:  Han Dai; David A Sinclair; James L Ellis; Clemens Steegborn
Journal:  Pharmacol Ther       Date:  2018-03-22       Impact factor: 12.310

Review 7.  Mitochondrial Sirtuins in Skin and Skin Cancers.

Authors:  Shengqin Su; Mary Ndiaye; Chandra K Singh; Nihal Ahmad
Journal:  Photochem Photobiol       Date:  2020-04-28       Impact factor: 3.421

Review 8.  Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.

Authors:  Jasmine George; Nihal Ahmad
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

Review 9.  The Role of Sirtuins in Antioxidant and Redox Signaling.

Authors:  Chandra K Singh; Gagan Chhabra; Mary Ann Ndiaye; Liz Mariely Garcia-Peterson; Nicholas J Mack; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2017-10-20       Impact factor: 8.401

10.  Rational Design of Novel Allosteric Dihydrofolate Reductase Inhibitors Showing Antibacterial Effects on Drug-Resistant Escherichia coli Escape Variants.

Authors:  Bharath Srinivasan; João V Rodrigues; Sam Tonddast-Navaei; Eugene Shakhnovich; Jeffrey Skolnick
Journal:  ACS Chem Biol       Date:  2017-05-31       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.